# PHASE 6 --- STAGE 2

# PRE-EXECUTION QA / END-STATE READINESS RECORD v0.1

Status: NOT READY --- NO-GO PREPARATION Date: 2026-08-15 Scope:
Controlled Chat UI + 239-PP Controlled Evaluation

## 1. QA objective

Verify the complete approved Phase 6 Stage 2 end-state surface before
GO/NO-GO: 1. Browser-based Controlled Chat UI 2. 239-case controlled
evaluation surface 3. Evidence capture 4. Execution baseline 5.
Knowledge/evidence baseline 6. Safety baseline 7. Runtime/environment 8.
Coverage mapping 9. Expected behavior 10. Clinical limitation/deferred
boundary

A PASS here would not itself authorize execution.

## 2. Governing baseline

The approved Stage 2 objective is: Controlled Chat UI + controlled
evaluation of all 239 Population Packages.

The project status and handover explicitly state that the current system
has only: - FastAPI API boundary - Swagger UI - POST /cer/evaluate -
PP-0002 + CKO controlled endpoint boundary - current evidence coverage
1/239

The custom Chat UI and multi-PP navigation are explicitly not yet
implemented.

## 3. QA results

### A. Controlled Chat UI

Result: FAIL / NOT READY

Evidence: - Current implementation is documented as API + Swagger UI,
not a custom chatbot UI. - No browser chat experience or multi-PP chat
navigation is evidenced. - Approved S2-B contract therefore cannot yet
be verified end-to-end.

Disposition: BLOCKING for the approved Stage 2 end-state.

### B. 239-case manifest

Result: PARTIAL / NOT READY

Evidence: - 239 cases exist. - 239 unique PP IDs. - 239 unique Case
IDs. - Manifest is v0.1-DRAFT. - Case Status = DRAFT. - Review Status =
PENDING_GOLD_CONTENT_REVIEW in the produced artifact. - Freeze Status =
NOT FROZEN. - Execution Status = PENDING.

The user's separate governance decision has closed Gold PP
eligibility/content review. Therefore the manifest's stale
`PENDING_GOLD_CONTENT_REVIEW` label must not be interpreted as a request
to reopen Gold PP review. It is a manifest-state artifact that must be
reconciled before execution.

Disposition: BLOCKING for execution readiness because the approved
execution surface is not yet frozen.

### C. Evidence-capture mechanism

Result: PASS

The corrected mechanism passed targeted operational verification with: -
Case ID - PP ID - Expected Behavior - Observed Behavior - Timestamp -
Run/Trace linkage - Safety linkage - Evidence/provenance linkage -
immutable record behavior

No Gold PP remediation required.

### D. Stage 1 evidence

Result: PASS / PRESERVED

CER Run #001 and Webapp Controlled Trial #001 remain PASS/CLOSED and are
not reopened.

### E. Gold PP population

Result: PASS / CLOSED

All 239 PP are explicitly approved as Gold PP / eligible. No PP content
or governance metadata is reopened by this QA.

### F. Knowledge / Evidence baseline

Result: PARTIAL

The repository/knowledge population is established and the 239 PP Gold
population is approved. However, the exact Stage 2 execution baseline
still needs to be frozen and linked to the execution manifest before GO.

### G. Safety baseline

Result: PARTIAL

Phase 5 safety enforcement is complete and the controlled runtime is
operationally runnable. However, the exact Phase 6 execution safety
configuration must be explicitly frozen/verified as part of the
execution baseline before GO.

### H. Runtime / environment

Result: PARTIAL

Stage 1 demonstrated the controlled CER HTTP runtime for PP-0002 + CKO.
Stage 2 has not yet demonstrated the browser Chat UI runtime or the
expanded 239-PP navigation/execution surface.

### I. Coverage mapping

Result: NOT READY

Current confirmed controlled-evaluation evidence remains: 1 / 239.

The manifest provides the intended 239-case denominator but does not
constitute execution evidence.

### J. Expected behavior

Result: PARTIAL

The case contract contains controlled questions and expected navigation
targets, but the manifest is not frozen and the browser Chat UI contract
has not been operationally demonstrated.

### K. Clinical limitation

Result: PASS / EXPLICIT

VC-CLIN remains: DEFERRED --- MISSING --- REQUIRES SOURCE / CLINICAL
INPUT.

This does not block the technical / controlled-evaluation readiness
work, but it prohibits claims of clinical validation or clinical
deployment authorization.

## 4. Overall Pre-Execution QA result

OVERALL: NOT READY

Primary blockers: 1. Controlled Chat UI is not implemented / not
operationally demonstrated. 2. 239-case evaluation manifest is not
frozen.

Secondary readiness work remains: - explicit execution baseline
freeze; - exact knowledge/evidence baseline linkage; - exact safety
configuration baseline verification; - Stage 2 runtime/browser
end-to-end verification.

## 5. Important governance disposition

This QA does NOT authorize: - 239-case execution; - browser Chat UI
execution; - formal validation; - clinical validation; - clinical
deployment; - execution authorization.

This QA does NOT require: - reopening Gold PP eligibility/content
review; - modifying Gold PP governance metadata; - reopening CER #001; -
reopening Webapp Trial #001; - creating an automatic remediation loop.

Any correction must occur at the layer where the issue originates.

## 6. GO / NO-GO status

Current state: NO-GO / NOT READY

Reason: The approved Stage 2 end-state surface has not yet been fully
demonstrated and the controlled evaluation surface is not frozen.

The next action is not execution. It is completion of the
already-approved Stage 2 end-state readiness work, followed by a fresh
Pre-Execution QA / GO-NO-GO assessment.
